Free Trial
LON:PXS

Provexis (PXS) Share Price, News & Analysis

GBX 0.72 -0.02 (-3.10%)
As of 11:58 AM Eastern

About Provexis Stock (LON:PXS)

Key Stats

Today's Range
0.72
0.72
50-Day Range
0.45
0.90
52-Week Range
0.06
0.95
Volume
43,738 shs
Average Volume
1.23 million shs
Market Capitalization
£16.90 million
P/E Ratio
N/A
Dividend Yield
5.06%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Provexis and its competitors with MarketBeat's FREE daily newsletter.

PXS Stock News Headlines

Paragon Care Limited (PXS) Receives a Buy from Ord Minnett
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
Provexis Share Chat (PXS)
Pyxis Tankers: Bet On A Strong MR Product Tankers Market
See More Headlines

PXS Stock Analysis - Frequently Asked Questions

Provexis' stock was trading at GBX 0.65 at the beginning of the year. Since then, PXS stock has increased by 10.8% and is now trading at GBX 0.72.

Provexis plc (LON:PXS) released its quarterly earnings data on Wednesday, September, 30th. The company reported ($0.02) earnings per share for the quarter. Provexis had a negative net margin of 73.10% and a negative trailing twelve-month return on equity of 68.68%.

Shares of PXS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Provexis investors own include Reckitt Benckiser Group (RB), Taylor Wimpey (TW), Bionano Genomics (BNGO), Bristol Myers Squibb (BMY), Bumble (BMBL), BEST (BEST) and Alibaba Group (BABA).

Company Calendar

Last Earnings
9/30/2020
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Transportation
Current Symbol
LON:PXS
CIK
N/A
Fax
N/A
Employees
4
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£619.15 thousand
Net Margins
-73.10%
Pretax Margin
N/A
Return on Equity
-68.68%
Return on Assets
-56.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.62
Quick Ratio
6.21

Sales & Book Value

Annual Sales
£846.98 thousand
Price / Sales
19.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
GBX 0.01 per share
Price / Book
83.94

Miscellaneous

Outstanding Shares
2,346,582,006
Free Float
N/A
Market Cap
£16.90 million
Optionable
Not Optionable
Beta
1.21
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:PXS) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners